Therapeutic approaches to Alzheimer’s disease
- 1 August 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 4 (4) , 377-382
- https://doi.org/10.1016/s1367-5931(00)00102-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- Modulation of amyloid β protein precursor processing as a means of retarding progression of Alzheimer’s diseaseJournal of Clinical Investigation, 1999
- A Combinatorial Approach to the Identification of Dipeptide Aldehyde Inhibitors of β-Amyloid ProductionJournal of Medicinal Chemistry, 1999
- Cleavage of Alzheimer's Amyloid Precursor Protein by α-Secretase Occurs at the Surface of Neuronal CellsBiochemistry, 1999
- Alzheimer’s DiseaseJournal of Neurochemistry, 1999
- Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide FormationCell, 1999
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992
- The molecular pathology of Alzheimer's diseaseNeuron, 1991